ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 165 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,793,000 | -25.8% | 144,170 | -18.3% | 0.02% | -33.3% |
| Q3 2016 | $2,416,000 | +11.5% | 176,480 | -39.8% | 0.02% | -4.0% |
| Q2 2016 | $2,167,000 | +3.2% | 293,280 | -10.8% | 0.02% | -10.7% |
| Q1 2016 | $2,100,000 | -76.3% | 328,620 | -76.8% | 0.03% | -72.8% |
| Q4 2015 | $8,868,000 | +21.1% | 1,418,866 | +13.1% | 0.10% | +21.2% |
| Q3 2015 | $7,325,000 | -29.4% | 1,254,286 | 0.0% | 0.08% | -23.4% |
| Q2 2015 | $10,373,000 | -12.0% | 1,254,286 | -12.3% | 0.11% | -9.8% |
| Q1 2015 | $11,790,000 | +24.4% | 1,430,830 | +3.7% | 0.12% | +23.0% |
| Q4 2014 | $9,476,000 | – | 1,379,360 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $94,961,000 | 26.95% |
| Consonance Capital Management LP | 8,845,742 | $65,370,000 | 9.25% |
| Opaleye Management Inc. | 1,250,000 | $9,238,000 | 6.17% |
| Tamarack Advisers, LP | 2,100,000 | $15,519,000 | 5.95% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 293,352 | $2,168,000 | 1.62% |
| Camber Capital Management LP | 4,000,000 | $29,560,000 | 1.43% |
| Palo Alto Investors LP | 2,535,117 | $18,735,000 | 1.42% |
| Granite Point Capital Management, L.P. | 430,890 | $3,184,000 | 1.37% |
| 1492 Capital Management LLC | 202,500 | $1,496,000 | 1.34% |
| HighVista Strategies LLC | 869,100 | $6,423,000 | 1.23% |